Skip to main content
Clinical Trials/NCT02802683
NCT02802683CompletedPhase 4

Hemodynamic Impact of Hyperbaric Versus Isobaric for Spinal Anesthesia During Cesarean Delivery

Seoul National University Hospital1 site in 1 country72 target enrollmentStarted: September 2015Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
72
Locations
1
Primary Endpoint
Number of hypotension events with treatment related

Study Overview

Brief Summary

The purpose of this study is to compare the frequency of hypotension between hyperbaric anesthetics and isobaric anesthetics during cesarean section and determine whether continuous infusion of phenylephrine is effective in mothers who received hyperbaric anesthetics.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
19 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • pregnant woman scheduled for elective cesarean delivery under spinal anesthesia

Exclusion Criteria

  • patients who refuse involved
  • patients who have pre-eclampsia
  • patients who have heart disease
  • patients who fetal distress is suspicious

Arms & Interventions

"BUPI","P"

Experimental

patients who received hyperbaric bupivacaine and continous infusion of phenylephrine

Intervention: Bupivacaine (Drug)

"BUPI","P"

Experimental

patients who received hyperbaric bupivacaine and continous infusion of phenylephrine

Intervention: Phenylephrine (Drug)

"BUPI","N"

Placebo Comparator

patients who received hyperbaric bupivacaine and continous infusion of normal saline

Intervention: Bupivacaine (Drug)

"BUPI","N"

Placebo Comparator

patients who received hyperbaric bupivacaine and continous infusion of normal saline

Intervention: normal saline (Drug)

"LEVO","P"

Experimental

patients who received isobaric levobupivacaine and continous infusion of phenylephrine

Intervention: Levobupivacaine (Drug)

"LEVO","P"

Experimental

patients who received isobaric levobupivacaine and continous infusion of phenylephrine

Intervention: Phenylephrine (Drug)

"LEVO","N"

Active Comparator

patients who received isobaric levobupivacaine and continous infusion of normal saline

Intervention: Levobupivacaine (Drug)

"LEVO","N"

Active Comparator

patients who received isobaric levobupivacaine and continous infusion of normal saline

Intervention: normal saline (Drug)

Outcomes

Primary Outcomes

Number of hypotension events with treatment related

Time Frame: during 30min after spinal anesthesia

blood pressure was obtained every 1min. A 20% decrease or more decrease in SAP compared to baseline was considered as hypotension. Hypotensive events during first 30 min was recorded as primary outcome.

Secondary Outcomes

  • total dose of phenylephrine(during the surgery)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jae-Hyon Bahk, MD, PhD

Professor

Seoul National University Hospital

Study Sites (1)

Loading locations...

Similar Trials

Hemodynamic Impact of Hyperbaric Versus... | Clinical Trial